[
  {
    "ts": null,
    "headline": "GEHC Stock Gains in Pre-Market Following Tie-Up Expansion With NVIDIA",
    "summary": "GE HealthCare aims to unlock automated solutions that enhance efficiency, easing the burden of increased volumes and staff shortages on healthcare professionals.",
    "url": "https://finnhub.io/api/news?id=3a1b07f2c1b37e5c8dc03ade7cb71ebef0d569b7bdeabb17a9128a833a613a10",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742403240,
      "headline": "GEHC Stock Gains in Pre-Market Following Tie-Up Expansion With NVIDIA",
      "id": 133325196,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "GE HealthCare aims to unlock automated solutions that enhance efficiency, easing the burden of increased volumes and staff shortages on healthcare professionals.",
      "url": "https://finnhub.io/api/news?id=3a1b07f2c1b37e5c8dc03ade7cb71ebef0d569b7bdeabb17a9128a833a613a10"
    }
  },
  {
    "ts": null,
    "headline": "HQY Stock Falls as Q4 Earnings Miss Estimates, Revenues Up Y/Y",
    "summary": "HealthEquity surpasses fourth-quarter revenue expectations on robust HSA growth. It also provided fiscal 2026 guidance.",
    "url": "https://finnhub.io/api/news?id=1844cefa105608fd81c869d130996900165253fb94fbac52711752eee470c39b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742402100,
      "headline": "HQY Stock Falls as Q4 Earnings Miss Estimates, Revenues Up Y/Y",
      "id": 133325197,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "HealthEquity surpasses fourth-quarter revenue expectations on robust HSA growth. It also provided fiscal 2026 guidance.",
      "url": "https://finnhub.io/api/news?id=1844cefa105608fd81c869d130996900165253fb94fbac52711752eee470c39b"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Retain AMED Stock in Your Portfolio Now",
    "summary": "Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.",
    "url": "https://finnhub.io/api/news?id=ae58c6e3b4406b5c3163ec48a73745f272894d92baef2ebceec9d4bad30f7136",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742397720,
      "headline": "Here's Why You Should Retain AMED Stock in Your Portfolio Now",
      "id": 133326605,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.",
      "url": "https://finnhub.io/api/news?id=ae58c6e3b4406b5c3163ec48a73745f272894d92baef2ebceec9d4bad30f7136"
    }
  },
  {
    "ts": null,
    "headline": "TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology",
    "summary": "Tandem Diabetes launches Control-IQ+ technology commercially in the United States. Control-IQ+ is compatible with t:slim X2 insulin pump and Tandem Mobi System.",
    "url": "https://finnhub.io/api/news?id=b6dd2eaf2248e438bf0b569cbb9eac40109dfe77f3b585026cf05f29706ae030",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742390280,
      "headline": "TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology",
      "id": 133302330,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Tandem Diabetes launches Control-IQ+ technology commercially in the United States. Control-IQ+ is compatible with t:slim X2 insulin pump and Tandem Mobi System.",
      "url": "https://finnhub.io/api/news?id=b6dd2eaf2248e438bf0b569cbb9eac40109dfe77f3b585026cf05f29706ae030"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock Equity Dividend V.I. Fund Q4 2024 Commentary",
    "summary": "The fund posted a return of -3.56% (Class I shares) for the fourth quarter of 2024. The largest exposures were in the financials, health care, and industrials sectors.",
    "url": "https://finnhub.io/api/news?id=d4e2e34f2dee9542a737f6db19a1890e386e8c811a105d55ded12b146e0f217a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742383140,
      "headline": "BlackRock Equity Dividend V.I. Fund Q4 2024 Commentary",
      "id": 133248142,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1158571563/image_1158571563.jpg?io=getty-c-w1536",
      "related": "CAH",
      "source": "SeekingAlpha",
      "summary": "The fund posted a return of -3.56% (Class I shares) for the fourth quarter of 2024. The largest exposures were in the financials, health care, and industrials sectors.",
      "url": "https://finnhub.io/api/news?id=d4e2e34f2dee9542a737f6db19a1890e386e8c811a105d55ded12b146e0f217a"
    }
  }
]